Ginkgo Bioworks stock rises after AI lab collaboration with OpenAI shows 40% cost reduction

Investing.com Nigeria·May 2

This story is reported by Investing.com Nigeria. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark

PR Newswire·Feb 5

2

Big Tech Targets Drug Discovery with Wave of Life Science Platforms

Genetic Engineering and Biotechnology News·May 4

3

How The Ginkgo Bioworks (DNA) Story Is Shifting As Analysts Revisit Growth And Risk

Yahoo Finance·Mar 14

4

Memory Chip Rout Sparks Doubt on AI's Market Leadership—Who Wins the Long Game?

finance.biggo.com·Jul 13

5

AWS launches Amazon Bio Discovery to accelerate AI-powered research in life sciences

About Amazon·Apr 14

6

Benchling bets lab automation can ground AI co-scientists in the physical world

R&D World·May 28

7

SLAS 2026: Orchestration patforms, API-first instruments and the rise of semiautonomous labs

drugdiscoverytrends.com·Feb 13

8

The Convergence Investor’s Cheat Sheet: 127 Companies Positioned at the Intersection of Future…

DataDrivenInvestor·Oct 22